Characteristics and outcomes of advanced melanoma patients with complete response and elective discontinuation of first-line anti-programmed death-1 monotherapy: A real-world multicentre observational cohort study.
Ochenduszko S, García Sanchez J, Fita MJJ, González-Barrallo I, Herrero Colomina J, Mujika K, Beveridge RD, Martínez SR, Lafuente BS, Tomas AC, Jaime AB, Cerezuela Fuentes P, Fra PL, Peeters AG, Meana García JA, García MAA, Altozano JP, Cancela M, Puchades AM, Roca FF, Maiques IM.
Ochenduszko S, et al. Among authors: lafuente bs.
Pigment Cell Melanoma Res. 2023 Sep;36(5):388-398. doi: 10.1111/pcmr.13093. Epub 2023 May 27.
Pigment Cell Melanoma Res. 2023.
PMID: 37243929